Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
352 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.810 | 1.000 | 1 | 2011 | 2017 | ||||
Breast Carcinoma
|
2145 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.100 | 0.786 | 14 | 2003 | 2019 | ||||
Malignant neoplasm of breast
|
2154 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.100 | 0.786 | 14 | 2003 | 2019 | ||||
Malignant Neoplasms
|
1441 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.070 | 0.714 | 7 | 2005 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.060 | 0.667 | 6 | 2005 | 2018 | ||||
Papillary thyroid carcinoma
|
193 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.030 | 1.000 | 3 | 2009 | 2016 | ||||
bilateral breast cancer
|
9 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.020 | 0.500 | 2 | 2005 | 2006 | ||||
Brain Neoplasms
|
85 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.020 | 1.000 | 2 | 2011 | 2015 | ||||
Astrocytoma
|
51 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Bladder Neoplasm
|
278 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Brain Tumor, Primary
|
8 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Carcinogenesis
|
355 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1 | 2016 | 2016 | |||||
Carcinoma of bladder
|
290 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Carcinoma of lung
|
995 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Carcinoma, Ovarian Epithelial
|
321 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
cervical cancer
|
257 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Cervix carcinoma
|
266 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Childhood Astrocytoma
|
39 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Diabetes
|
611 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Diabetes Mellitus
|
714 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Differentiated Thyroid Gland Carcinoma
|
72 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1 | 2015 | 2015 | |||||
Endometriosis
|
207 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Familial (FPAH)
|
276 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Malignant neoplasm of lung
|
1000 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of ovary
|
246 | 0.627 | 0.400 | 11 | 108304735 | missense variant | G/A | snv | 0.11 | 0.11 | 0.010 | 1.000 | 1 | 2015 | 2015 |